Sai Life Science Ltd. IPO

Q: What is the size of Sai Life Science Ltd. IPO?

The size of the Sai Life Science Ltd. IPO is &#8377;3,042.62 Cr.

Q: What is the price range of Sai Life Science Ltd. IPO?

The price range of Sai Life Science Ltd. IPO is at &#8377;522 to &#8377;549 per share.

Q: What is the minimum investment and lot size required for the Sai Life Science Ltd. IPO?

The minimum investment required is &#8377;14,823 and minimum lot size is 27 shares.

Sai Life Science Ltd., established in 1999, operates in the Pharmaceuticals sector. The company's IPO opened on December 11, 2024 and closed on December 13, 2024, with an issue price of ₹549. The Sai ... Read more

Min Investment

₹ 14,823 / 27 shares

Price Range

₹522 - ₹ 549

Bidding Dates

11 Dec '24 - 13 Dec '24

Total Issue Value

3,042.62 Cr

Lot Size

Total Issue Size

3,042.62 Cr

Listing At

BSE, NSE

Subscription

7.51 times

BSE Price

751.25 (36.84%)

NSE Price

751.20 (36.83%)

IPO Timeline

11 Dec 2024

Bidding Starts
13 Dec 2024

Bidding Ends
16 Dec 2024

Allotment Finalization
18 Dec 2024

Listing

About Sai Life Science Ltd.

We are a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. We provide end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators ... Read more

Parent organisation

Founded

Sai Life Science Ltd.

1999

Sai Life Science Ltd. IPO Reservation

Investors Category	Shares Offered
Anchor Investors	1,66,26,337 (30%)
Non Institutional Investors	83,13,169 (15%)
Qualified Institutional Buyers (QIBs)	1,10,84,225 (20%)
Retail Individual Investors (RIIs)	1,93,97,393 (35%)

Sai Life Science Ltd. Financial Information

Year End	Revenue	PAT	Reserves & Surplus
31 Mar 2024	1,448.01 Cr	95.23 Cr	982.54 Cr
31 Mar 2023	1,185.36 Cr	24.24 Cr	885.25 Cr
31 Mar 2022	869.17 Cr	15.68 Cr	864.37 Cr

Sai Life Science Ltd. Background

Major Events And Milestones

1999

Incorporation of our Company
2002

Inauguration of our R&D labs in ICICI Knowledge Park, Hyderabad.
2004

Strategic acquisitions of Prasad Drugs Limited, the current Unit III Bolarum Facility
2006

Investment by Advantium LLC in our Company to set-up discovery services to expand our Company’s business.
Acquired Merrifield Pharma Private Limited
2007

Acquisition of shares of our Company held by Advantium LLC by Sequoia Capital India Investments III
2008

Investment by MPM Investment Mauritius in our Company
2014

Acquisition of shares of our Company held by MPM Investment Mauritius and Sequoia Capital India Investment III by Tata Capital Healthcare Fund 1
2016

Acquisition of shares of our Company held by MPM Investment Mauritius by HBM Private Equity India and subscription to shares of our Company
2019

Opened biology facility in Watertown (Greater Boston, MA) U.S.A
2020

Launched Sai Nxt, an initiative aiming to transform the organization into a new generation CDMO
Addition of cellular analysis platforms at our discovery biology facility in Cambridge, Massachusetts, USA
2021

Opened new 75,000 sq. ft. discovery biology facility at our integrated R&D campus at Unit II Hyderabad Facility
2022

Inauguration of the first set of new discovery chemistry labs as part of the new integrated discovery block at Unit II Hyderabad Facility
Announced the launch of BIOVIA Electronic Lab Notebook application
2023

Inauguration of high potency API manufacturing block at Unit IV Bidar Facility.
2024

Initiated API developability & formulations (D&F) capabilities at Unit II Hyderabad

Sai Life Science Ltd. Object of Issues

1. Repayment/ pre-payment, in part or full, of all or certain outstanding borrowings availed by our Company
2. General corporate purposes

Sai Life Science Ltd. IPO Listing Details

Listing Date

18 Dec 2024

BSE Script Code

SAILIFE

NSE Symbol

SAILIFE

ISIN

INE570L01029

Final Issue Price

₹ 549

Sai Life Science Ltd. Listing Day Trading Information

Pricing Details	BSE	NSE
Issue Price	₹ 549.00	₹ 549.00
Open	₹ 660.00	₹ 650.00
Low	₹ 651.20	₹ 650.00
High	₹ 787.35	₹ 780.00
Last Trade	₹ 765.30	₹ 764.65

Sai Life Science Ltd. Company Promoters

1. Kanumuri Ranga Raju
2. Krishnam Raju Kanumuri
3. Kanumuri Mytreyi
4. Sai Quest Syn Private Limited
5. Marigold Partners
6. Sunflower Partners
7. Tulip Partners
8. Lily Partners

Industry Overview

The global small molecule contract research, development and manufacturing organization industry is forecasted to reach US$159 billion by 2028 (comprising approximately 53% of the overall global contract research, development and manufacturing organization industry), driven by increasing ... Read more

Sai Life Science Ltd. Contact Details

Address: Plot No. DS- 7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Medchal Malkajgiri District, Hyderabad Telangana - 500078
Phone no:6815600

Email: [email protected]

6815600

Visit Website

Sai Life Science Ltd. IPO Registrar

KFin Technologies Ltd.

Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally Hyderabad Telangana - 500032

67162222

Sai Life Science Ltd. IPO Lead Manager(s)

Jefferies India Pvt. Ltd.

16th Floor, Express Towers, Nariman Point, Mumbai Maharashtra - 400021

4356600

FAQs

When does Sai Life Science Ltd. IPO opens and closes?

Sai Life Science Ltd. IPO opens from 11th December to 13th December 2024.

What is the size of Sai Life Science Ltd. IPO?

The size of the Sai Life Science Ltd. IPO is ₹3,042.62 Cr.

What is the price range of Sai Life Science Ltd. IPO?

The price range of Sai Life Science Ltd. IPO is at ₹522 to ₹549 per share.

What is the minimum investment and lot size required for the Sai Life Science Ltd. IPO?

The minimum investment required is ₹14,823 and minimum lot size is 27 shares.

When is Sai Life Science Ltd. IPO listing date?

The Sai Life Science Ltd. IPO will be listed on 18th December 2024.

What is the objective of Sai Life Science Ltd. IPO?

1. Repayment/ pre-payment, in part or full, of all or certain outstanding borrowings availed by our Company
2. General corporate purposes

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article